NDC 37662-1751

Laurocerasus

Laurocerasus

Laurocerasus is a Oral Pellet in the Human Otc Drug category. It is labeled and distributed by Hahnemann Laboratories, Inc.. The primary component is Prunus Laurocerasus Leaf.

Product ID37662-1751_ebcf970f-96ec-f0a7-e053-2995a90a07ad
NDC37662-1751
Product TypeHuman Otc Drug
Proprietary NameLaurocerasus
Generic NameLaurocerasus
Dosage FormPellet
Route of AdministrationORAL
Marketing Start Date2022-10-24
Marketing CategoryUNAPPROVED HOMEOPATHIC /
Labeler NameHahnemann Laboratories, INC.
Substance NamePRUNUS LAUROCERASUS LEAF
Active Ingredient Strength12 [hp_C]/1
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 37662-1751-1

200 PELLET in 1 VIAL, GLASS (37662-1751-1)
Marketing Start Date2022-10-24
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "Laurocerasus" or generic name "Laurocerasus"

NDCBrand NameGeneric Name
0220-3069LaurocerasusPRUNUS LAUROCERASUS LEAF
15631-0270LAUROCERASUSLAUROCERASUS
37662-1750LaurocerasusLaurocerasus
37662-1751LaurocerasusLaurocerasus
37662-1752LaurocerasusLaurocerasus
37662-1753LaurocerasusLaurocerasus
37662-1754LaurocerasusLaurocerasus
37662-1755LaurocerasusLaurocerasus
37662-1756LaurocerasusLaurocerasus
37662-1757LaurocerasusLaurocerasus
37662-1758LaurocerasusLaurocerasus
68428-970LaurocerasusPRUNUS LAUROCERASUS LEAF
71919-407LaurocerasusPRUNUS LAUROCERASUS LEAF

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.